Stock-Callers.com has initiated coverage on the following equities: Northwest Biotherapeutics Inc. (NASDAQ: NWBO), …
If you want a Stock Review on ATHX, AVEO, HTBX, or RXDX then come over to http://dailystocktracker.com/register/ …
KFVS122mon
Athersys Inc. (ATHX) plans to sell more than 19.8 million common shares ... The news of the offering at a steep discounted price crushed the company's stock price on Friday, which closed at $1.12 per share, down 27% from the …
If you want a Stock Review on ATHX, AVEO, HTBX, or RXDX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Wednesday, the NASDAQ Composite ended the day at 6,261.17, up …
WDRB2mon
Athersys, Inc. (Nasdaq: ATHX), entered into a Common Stock Purchase Agreement with Aspire Capital Fund, LLC whereby Aspire Capital has committed to purchase up to $20 million of Athersys' common stock in multiple …
January 26, 2017 16:28 ET | Source: Athersys, Inc. CLEVELAND, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) announced today that it intends to offer for sale shares of its common stock, par value …
Athersys Inc. (ATHX) suffered a blow on Friday with the stock price dropping to a new 52-week low, on news that the primary and secondary endpoints of the company's phase II study of MultiStem cell therapy for treatment of ischemic …
Athersys, Inc. (Nasdaq: ATHX) announced today that it has priced its offering of common stock. The Company has agreed to sell 19,802,000 shares of common stock through an underwritten public offering at $1.01 per share, which was the …
A former custodian with stem cell developer Athersys (NASDAQ:ATHX) has been accused by federal prosecutors of running a stock scam that bilked would-be investors out of $340,000 over six years. Ronald Olear, 57, in some cases …